close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oculis Holding AG - Ordinary shares (NQ:OCS)

7.580 -0.040 (-0.52%)
Delayed Quote Updated: 10:04 AM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Oculis Holding AG - Ordinary shares

< Previous 1 2 Next >
Oculis (NASDAQ:OCS) Beats Q2 Estimates and Advances Late-Stage Neuro-Ophthalmology Pipeline ↗
Via Chartmill
News headline image
Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles ↗
Oculis advances late-stage topical therapies for diabetic and neuro-ophthalmic eye diseases in the clinical-stage biotech sector. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters. ↗
This clinical-stage biotech targets chronic pruritus and cough with its lead therapy for neurologically mediated diseases. 
Via The Motley Fool
Topics Regulatory Compliance
Which stocks are experiencing notable movement on Monday? ↗
Via Chartmill
Oculis Holding AG (NASDAQ:OCS) Q1 Earnings Miss Overshadowed by Key Pipeline Catalysts ↗
Via Chartmill
Topics Earnings
Oculis Holding AG (NASDAQ:OCS) Reports Q4 2025 Earnings Beat, Focus Remains on 2026 Clinical Catalysts ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
Which stocks are moving on Monday? ↗
Via Chartmill
Monday's session: gap up and gap down stocks ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
Oculis Shelves FDA Filing After Phase 3 DME Trials Miss Key Vision Goals ↗
Oculis (NASDAQ:OCS) said its two Phase 3 DIAMOND trials of OCS-01 in diabetic macular edema did not meet their primary endpoints, and the company does not currently plan to pursue a U.S. Food and Drug... 
Via MarketBeat
News headline image
Uncovering Potential: Oculis Holding's Earnings Preview ↗
 
Via Benzinga
News headline image
Expert Ratings for Oculis Holding ↗
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Oculis Holding ↗
 
Via Benzinga
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Zoom To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
Oculis Holding AG (NASDAQ:OCS) Reports Q3 2025 Earnings Beat and Provides Key Clinical Pipeline Updates ↗
Oculis (OCS) beat Q3 2025 earnings estimates, extended cash runway into 2029, and advanced its late-stage ophthalmology pipeline with key clinical milestones ahead. 
Via Chartmill
Topics Earnings
News headline image
Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
Expert Ratings for Oculis Holding ↗
 
Via Benzinga
News headline image
This CoreWeave Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 21, 2025 ↗
 
Via Benzinga
News headline image
Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday ↗
 
Via Benzinga
News headline image
Intuit To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
OCS Stock Earnings: Oculis Holding Misses EPS, Misses Revenue for Q1 2024 ↗
OCS stock results show that Oculis Holding missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
FLJ Group, Bit Digital And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗
U.S. stock futures were slightly higher this morning, with the Dow Jones futures gaining around 15 points on Thursday. Shares of FLJ Group Limited(NASDAQ: FLJ) rose sharply in pre-market trading. 
Via Benzinga
Topics Stocks
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023 ↗
 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.